Donald A. Kalkofen - Chief Financial Officer at Protagonist Therapeutics, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
PTGX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Donald A. Kalkofen since 13 Feb 2025

Holdings reported by Donald A. Kalkofen for Protagonist Therapeutics, Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18,521 $456,172 $24.63 15 Feb 2022 Direct
Stock Option (right to buy) 45,000 15 Feb 2022 Direct Common Stock

Transactions reported by Donald A. Kalkofen for Protagonist Therapeutics, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.